Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Merck & Co., Inc.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Target Audience: The intended audience for this activity is oncologists, oncology nurses, oncology pharmacists, oncology nurse practitioners, oncology physician assistants and other health care professionals involved in the treatment of patients with bladder cancer.
Learning Objectives:
Physician and Nurse
- Implement treatment strategies that reflect the latest clinical evidence regarding the use of immune checkpoint inhibitors for patients with advanced bladder cancer.
Pharmacist
- Assess the latest clinical evidence regarding the use of immune checkpoint inhibitors for the treatment of patients with bladder cancer.
All
- Evaluate the benefits and limitations of traditional treatment options for patients with advanced bladder cancer.
- Identify immune-related adverse events in a timely manner and manage appropriately.
Activity Chair:
Daniel G. Chong, MD
Medical Oncology
Virginia Cancer Specialists
Fairfax, VA
Faculty:
Mark T. Fleming, MD
Medical Director
Genitourinary Program
US Oncology
Norfolk, VA
Physician Reviewer
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
Pharmacy Reviewer
Jennifer Frederick, PharmD, BCPS
Nurse Reviewers
Rajni Kannan, BS, MS, RN, ANP-BC
Barbara A. Niedz, PhD, RN, CPHQ
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education will provide 0.5 contact hours for nurses.
This program is acceptable for 0.5 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-18-004-H01-P, effective 2/23/2018. This is a knowledge-based activity and there is no fee to attend.
This enduring material is approved for 1 year from the date of original release, February 23, 2018 to Febraury 23, 2019.
How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, review the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s) Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty report the following relationships:
Daniel G. Chong, MD
No relevant financial relationships to disclose.
Mark T. Fleming, MD
No relevant financial relationships to disclose.
Reviewers report the following relationship(s):
Ronald A. Codario MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Frederick PharmD, BCPS
No relevant financial relationships to disclose.
Rajni Kannan, BS, MS, RN, ANP-BC
Speakers Bureau: Bristol-Myers Squibb
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com